(S)-(+)-3-Quinuclidinol CAS 34583-34-1 Purity ≥99.0% Factory High Quality
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of (S)-(+)-3-Quinuclidinol (CAS: 34583-34-1) with high quality. Ruifu Chemical has been supplying pharmaceutical intermediates and APIs, fine chemicals more than 15 years. Ruifu Chemical can provide competitive price, excellent service. Purchase (S)-(+)-3-Quinuclidinol or other products, please contact us by e-mail: alvin@ruifuchem.com
Commercial Supply Solifenacin Succinate Intermediates:
Solifenacin Succinate CAS: 242478-38-2
(R)-(-)-3-Quinuclidinol CAS: 25333-42-0
(S)-(+)-3-Quinuclidinol CAS: 34583-34-1
3-Quinuclidinone Hydrochloride CAS: 1193-65-3
1-Phenyl-1,2,3,4-Tetrahydro-Isoquinoline CAS: 22990-19-8
(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS: 118864-75-8
Chemical Name | (S)-(+)-3-Quinuclidinol |
Synonyms | (S)-Quinuclidin-3-ol; (S)-(+)-3-Hydroxyquinuclidine; (3S)-1-Azabicyclo[2.2.2]octan-3-ol; Solifenacin Succinate Intermediate B; |
CAS Number | 34583-34-1 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C7H13NO |
Molecular Weight | 127.18 |
Melting Point | 215.0~217.0℃ |
Density | 1.13±0.10 g/cm3 |
COA & MSDS | Available |
Origin of Product | Shanghai, China |
Product Categories | Pharmaceutical Intermediates; Chiral Compounds; |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | Off-White to White Crystalline Powder |
Identification IR Specturm | Conforms to Reference Spectrum |
Specific Rotation [α]D20 | 44.0°±2.0° |
Loss On Drying | ≤0.50% |
Purity | ≥99.0% |
Assay | 98.0%~102.0% (on Anhydrous Basis) |
Test Standard | Enterprise Standard |
Usage | Chiral Compounds; Pharmaceutical Intermediates |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry (2~8℃), well-ventilated warehouse away from incompatible substances. Keep away from sunshine; avoid fire and heat sources; avoid moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Safety Description 24/25 - Avoid contact with skin and eyes.
HS Code 2933350000
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-(+)-3-Quinuclidinol (CAS: 34583-34-1) with high quality, widely used in synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API). (S)-(+)-3-Quinuclidinol is an intermediate in the synthesis of Solifenacin Succinate API (CAS: 242478-38-2). Solifenacin Succinate is an antimuscarinic medication that is used to treat an overactive bladder causing symptoms of frequency, urgency, or incontinence. It is an M3 muscarinic receptor antagonist that was developed and launched for the treatment of overactive bladder (pollakiuria) in Europe. M3 receptors have been implicated in neurally evoked smooth muscle contractions of the bladder, and M2 receptors have also been suspected of playing a role because of their dominance in the detrusor muscle.